Red flags requiring immediate attention include: Unexplained weight gain while on semaglutide Severe or persistent gastrointestinal symptoms Signs of pancreatitis (severe abdominal pain radiating to the back) Symptoms of gallbladder disease (right upper quadrant pain, fever, jaundice) Signs of dehydration or kidney problems (decreased urination, dizziness) Hypoglycemia symptoms if taking insulin or sulfonylureas Depression or suicidal thoughts Symptoms of thyroid problems (neck mass, difficulty swallowing, persistent hoarseness) Pregnancy or planning pregnancy (semaglutide should be discontinued at least 2 months before a planned pregnancy) These situations require prompt medical evaluation rather than waiting for a routine follow-up appointment
The State of Telehealth Before and After the COVID-19 Pandemic
You do not inject milligrams
Dosing typically starts at 1mg weekly and gradually increases to 4mg or higher, with most users finding their sweet spot between 4mg and 8mg when combined with anabolic compounds
Understanding the relationship between GLP-1 therapy and skeletal health helps patients and clinicians make informed decisions whilst implementing strategies to protect bone integrity during treatment
This explains why ferroptosis has emerged as a common pathological pathway in multiple, seemingly unrelated diseases